Sudeep Pharma Stock Performance Analyzed
As of 10:20 AM IST today, Sudeep Pharma’s stock is trading at Rs 764.05, which is 28.84% higher than when it first started trading. This means investors are paying a premium—about 24% more—than the initial price of Rs 593 per share. The stock started its journey at Rs 733.95, also a premium of 23.77%.
Key Points
- Stock price at Rs 764.05, a significant premium.
- Initial listing price was Rs 733.95, a 23.77% premium.
- Over 20.87 million shares traded today.
- IPO was subscribed 93.72 times, showing high demand.
- Raised Rs 268.49 crore from anchor investors before listing.
- Company focuses on excipients and ingredients for pharma & food.
Sudeep Pharma had a really good IPO. Investors were so eager to buy shares that the company raised Rs 268.49 crore before it even started trading. This happened because 25 big investors—called “anchor investors”—bought shares ahead of time.
The company’s main goal for raising this money is to buy new equipment for its factory in Nandesari. They also plan to use some of the money for general business expenses. The people running the company—called “promoters”—already own a big chunk of the business—almost 90%!
Sudeep Pharma makes special ingredients for making medicines, food, and supplements. They have two main sections. One section makes basic ingredients like calcium, zinc, and iron. The other section creates more advanced ingredients using special technology. These ingredients are used in things like vitamin pills, baby food, and even snacks.
In the first three months of the year starting June 2025 (Q1 FY26), about 66% of the company’s sales came from its main ingredients section, and the rest came from its special ingredients section. A lot of their sales—around 41%—are in India, and they also sell their products to other countries.
Before the IPO, the company made a profit of Rs 30.81 crore and sold products worth Rs 124.92 crore in the last three months (Q1 FY26). This shows the company’s sales and profitability are growing.
Ultimately, Sudeep Pharma is a growing company with strong investor interest, pointing to a promising future.
